• 作者：J. Cabrera^a ; M. Mancuso^b ; F. Cabrera-Frá ; nquiz^c ; J. Limiñ ; ana^d ; A. Dí ; ez^e ; ^{alicia.diezpino@gobiernodecanarias.org}
• 关键词：Tramadol ; Ketorolaco ; Metoclopramida ; Ranitidina ; Analgesia multimodal
• 刊名：Farmacia Hospitalaria
• 出版年：2011
• 期刊代码：pca388_11306343
• 类别：pha
• 出版时间：March-April 2011
• 卷：35
• 期：2
• 页码：80-83
• 文件大小：125 K

Objective

To determine whether a mixture for intravenous perfusion containing tramadol (5 mg/ml), ranitidine (1.5 mg/ml), ketorolac (1.5 mg/ml) and metoclopramide (0.5 mg/ml) in a 0.9%sodium chlorides solution is compatible and stable at room temperature during a 48-hour period.

Methods

We tested the mixture for stability using the HPLC technique (high performance liquid chromatography), with parallel visual assessments of any changes in colour, appearance of precipitate or phase separation indicating incompatibilities between the components.

Results

At the end of the trial, chromatography data showed a mean metoclopramide concentration between 100%and 105%of the initial level, while concentrations of tramadol, ketorolac and ranitidine were between 99%and 102%of initial levels. There was no evidence of incompatibility between the drugs at any time during the study period.

Conclusions

The combination is stable as a solution and its components are physically and chemically compatible in the concentrations used in the study, during at least 48 hours at room temperature.